Literature DB >> 27145111

Determination of Metabolic Viability and Cell Mass Using a Tandem Resazurin/Sulforhodamine B Assay.

Filomena S G Silva1,2, Irina G Starostina3,2, Vilena V Ivanova3, Albert A Rizvanov3, Paulo J Oliveira1, Susana P Pereira4.   

Abstract

The identification of rapid, reliable, and highly reproducible biological assays that can be standardized and routinely used in preclinical tests constitutes a promising approach to reducing drug discovery costs and time. This unit details a tandem, rapid, and reliable cell viability method for preliminary screening of chemical compounds. This assay measures metabolic activity and cell mass in the same cell sample using a dual resazurin/sulforhodamine B assay, eliminating the variation associated with cell seeding and excessive manipulations in assays that test different cell samples across plates. The procedure also reduces the amount of cells, test compound, and reagents required, as well as the time expended in conventional tests, thus resulting in a more confident prediction of toxic thresholds for the tested compounds. © 2016 by John Wiley & Sons, Inc.
Copyright © 2016 John Wiley & Sons, Inc.

Entities:  

Keywords:  high throughput; human skin fibroblasts; preclinical tests; toxicity evaluation

Mesh:

Substances:

Year:  2016        PMID: 27145111     DOI: 10.1002/cptx.1

Source DB:  PubMed          Journal:  Curr Protoc Toxicol        ISSN: 1934-9254


  10 in total

1.  Cell quality control mechanisms maintain stemness and differentiation potential of P19 embryonic carcinoma cells.

Authors:  Silvia Magalhães-Novais; Juan C Bermejo-Millo; Rute Loureiro; Katia A Mesquita; M Rosário Domingues; Elisabete Maciel; Tânia Melo; Inês Baldeiras; Jenna R Erickson; Jon Holy; Yaiza Potes; Ana Coto-Montes; Paulo J Oliveira; Ignacio Vega-Naredo
Journal:  Autophagy       Date:  2019-04-24       Impact factor: 16.016

2.  nurP28, a New-to-Nature Zein-Derived Peptide, Enhances the Therapeutic Effect of Docetaxel in Breast Cancer Monolayers and Spheroids.

Authors:  Plinio Alejandro Trinidad-Calderón; Laura Margarita López-Castillo; Salvador Gallegos-Martínez; Grissel Trujillo-de Santiago; Silverio García-Lara; Mario Moisés Álvarez
Journal:  Molecules       Date:  2022-04-29       Impact factor: 4.927

3.  Hydroxybenzoic Acid Derivatives as Dual-Target Ligands: Mitochondriotropic Antioxidants and Cholinesterase Inhibitors.

Authors:  Catarina Oliveira; Fernando Cagide; José Teixeira; Ricardo Amorim; Lisa Sequeira; Francesco Mesiti; Tiago Silva; Jorge Garrido; Fernando Remião; Santiago Vilar; Eugenio Uriarte; Paulo J Oliveira; Fernanda Borges
Journal:  Front Chem       Date:  2018-04-23       Impact factor: 5.221

4.  Afrostyrax lepidophyllus Mildbr. and Monodora myristica (Gaertn.) Dunal Extracts Decrease Doxorubicin Cytotoxicity on H9c2 Cardiomyoblasts.

Authors:  Bruno M Moukette; José P Castelão-Baptista; Luciana Ferreira; Ana M Silva; Rui F Simões; Célia Cabral; Constant A Pieme; Jeanne Y Ngogang; Vilma A Sardão; Paulo J Oliveira
Journal:  Evid Based Complement Alternat Med       Date:  2021-02-22       Impact factor: 2.629

5.  Cytotoxicity and Mitochondrial Effects of Phenolic and Quinone-Based Mitochondria-Targeted and Untargeted Antioxidants on Human Neuronal and Hepatic Cell Lines: A Comparative Analysis.

Authors:  Carlos Fernandes; Afonso J C Videira; Caroline D Veloso; Sofia Benfeito; Pedro Soares; João D Martins; Beatriz Gonçalves; José F S Duarte; António M S Santos; Paulo J Oliveira; Fernanda Borges; José Teixeira; Filomena S G Silva
Journal:  Biomolecules       Date:  2021-10-29

6.  Riluzole-Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis.

Authors:  Claudia Albertini; Alessandra Salerno; Silvia Atzeni; Elisa Uliassi; Francesca Massenzio; Annalisa Maruca; Roberta Rocca; Marko Mecava; Filomena S G Silva; Débora Mena; Pedro Valente; Ana I Duarte; Daniel Chavarria; Maicol Bissaro; Stefano Moro; Stephanie Federico; Giampiero Spalluto; Ondřej Soukup; Fernanda Borges; Stefano Alcaro; Barbara Monti; Paulo J Oliveira; Josè C Menéndez; Maria Laura Bolognesi
Journal:  ACS Chem Neurosci       Date:  2022-07-22       Impact factor: 5.780

7.  Targeting Hydroxybenzoic Acids to Mitochondria as a Strategy to Delay Skin Ageing: An In Vitro Approach.

Authors:  Carlos Fernandes; Fernando Cagide; Jorge Simões; Carlos Pita; Eurico Pereira; Afonso J C Videira; Pedro Soares; José F S Duarte; António M S Santos; Paulo J Oliveira; Fernanda Borges; Filomena S G Silva
Journal:  Molecules       Date:  2022-09-21       Impact factor: 4.927

8.  A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients.

Authors:  Cláudia M Deus; Susana P Pereira; Teresa Cunha-Oliveira; José Teixeira; Rui F Simões; Fernando Cagide; Sofia Benfeito; Fernanda Borges; Nuno Raimundo; Paulo J Oliveira
Journal:  Redox Biol       Date:  2021-06-08       Impact factor: 11.799

9.  Exploratory Data Analysis of Cell and Mitochondrial High-Fat, High-Sugar Toxicity on Human HepG2 Cells.

Authors:  Ricardo Amorim; Inês C M Simões; Caroline Veloso; Adriana Carvalho; Rui F Simões; Francisco B Pereira; Theresa Thiel; Andrea Normann; Catarina Morais; Amália S Jurado; Mariusz R Wieckowski; José Teixeira; Paulo J Oliveira
Journal:  Nutrients       Date:  2021-05-19       Impact factor: 5.717

10.  Evaluation of 6-Hydroxydopamine and Rotenone In Vitro Neurotoxicity on Differentiated SH-SY5Y Cells Using Applied Computational Statistics.

Authors:  Rui F Simões; Paulo J Oliveira; Teresa Cunha-Oliveira; Francisco B Pereira
Journal:  Int J Mol Sci       Date:  2022-03-10       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.